Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer

by Ida Skarping, Daniel Förnvik, Hanna Sartor, Uffe Heide-Jørgensen, Sophia Zackrisson, Signe Borgquist
Published 2019-12-01

Mammographic density changes during neoadjuvant breast cancer treatment: NeoDense, a prospective study in Sweden

by Ida Skarping, Daniel Förnvik, Uffe Heide-Jørgensen, Hanna Sartor, Per Hall, Sophia Zackrisson, Signe Borgquist
Published 2020-10-01